http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012101653-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15c4301cb7d6efb2ad99c192d652f96b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2918ef26a5220c142f82d5eb1d569b4c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_70dbf810632efb840219379bf6dfc8f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ecbaf12eab14b75e7c036c7308d652e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3166d2820b5872ab84d235e5fae1d45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd6a6a99b17b4912eda2cbdd71de65f5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
filingDate 2012-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2bfaabec5eac43abf1bf142e1dc995e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8987ad882f97c3c0a7a720304ddf6604
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4fbb919c95a4b57e222a21ecc9e083a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cc441b4832063a9d1170039b055b236
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e36b9a6156ae41e986f7969cde049dc6
publicationDate 2012-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2012101653-A3
titleOfInvention Modified release pharmaceutical compositions memantine
abstract The invention relates to modified release pharmaceutical compositions of memantine or pharmaceutically acceptable salts thereof. The compositions of invention are stable, possessing improved formulation characteristics and also provide extended therapeutically effective plasma levels over twenty four hours period. The invention also relates to processes of making such compositions.
priorityDate 2011-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006138227-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006058059-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505100
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1263681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395070

Total number of triples: 31.